Chi-chang David Lin is a New York, New York based physiatrist with 26 years of experience in Physical Medicine & Rehabilitation (PM&R). He completed his graduation from University Of Alabama School Of Medicine in 1999. He is also affiliated with hospitals like New York-presbyterian Hospital and Hospital For Special Surgery. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Chi-chang David Lin as Physical Medicine & Rehabilitation (PM&R) is 224242 in New York.
Chi-chang David Lin is specialized in diagnosing, evaluating, and treating patients with physical disabilities. These disabilities may arise from conditions affecting the musculoskeletal system such as neck and back pain, sports injuries, or other painful conditions affecting the limbs, such as carpal tunnel syndrome. Alternatively, the disabilities may result from neurological trauma or disease such as spinal cord injury, head injury or stroke. The primary goal of the physiatrist is to achieve maximal restoration of physical, psychological, social and vocational function through comprehensive rehabilitation. Pain management is often an important part of the role of the physiatrist. For diagnosis and evaluation, a physiatrist may include the techniques of electromyography to supplement the standard history, physical, x-ray and laboratory examinations. He has expertise in the appropriate use of therapeutic exercise, prosthetics (artificial limbs), orthotics and mechanical and electrical devices.
Complete Profile:
Chi-chang David Lin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Physical Medicine & Rehabilitation (PM&R)
Credentials:
MD
Experience:
26+ years
Medical School Attended:
University Of Alabama School Of Medicine
Graduation Year:
1999
Gender:
Male
Accepts Medicare Assignment:
Yes
Practice Address:
525 East 68th Street, Baker 116, New York, New York, 10021
Phone:
212-746-1500
Fax:
212-746-8303
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
3375456585
Enrollment ID:
I20031112000370
NPI Number:
1831287119
NPI Enumeration Date:
11 Oct, 2006
NPI Last Update On:
20 Jul, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Chi-chang David Lin are as mentioned below.
License Number
Specialization
State
Status
224242
Physiatrist
New York
Primary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN)
State
Hospital Type
New York-presbyterian Hospital (330101)
New york, NY
Acute Care Hospital
Hospital For Special Surgery (330270)
New york, NY
Acute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Chi-chang David Lin is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
Weill Medical College Of Cornell (6800709023)
1529
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
525 E 68th St # F16, New York, New York
Zip:
10065-4870
Phone Number:
212-746-1500
Fax Number:
212-746-8303
Patients can reach Chi-chang David Lin at 525 East 68th Street, Baker 116, New York, New York or can call to book an appointment on 212-746-1500. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.